Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circovirus | 7 | 2021 | 11 | 3.210 |
Why?
|
| Capsid Proteins | 9 | 2021 | 74 | 1.890 |
Why?
|
| Capsid | 9 | 2019 | 64 | 1.780 |
Why?
|
| DNA, Single-Stranded | 3 | 2023 | 39 | 1.180 |
Why?
|
| Brassicaceae | 2 | 2023 | 3 | 1.040 |
Why?
|
| Viruses | 2 | 2021 | 39 | 0.900 |
Why?
|
| HIV Envelope Protein gp120 | 6 | 2013 | 52 | 0.800 |
Why?
|
| DNA Viruses | 2 | 2021 | 14 | 0.800 |
Why?
|
| Cryoelectron Microscopy | 12 | 2020 | 48 | 0.760 |
Why?
|
| Viruses, Unclassified | 1 | 2021 | 3 | 0.740 |
Why?
|
| Circoviridae Infections | 2 | 2019 | 4 | 0.740 |
Why?
|
| Virion | 6 | 2019 | 73 | 0.740 |
Why?
|
| Translocation, Genetic | 1 | 2021 | 40 | 0.710 |
Why?
|
| Plasmids | 1 | 2021 | 247 | 0.680 |
Why?
|
| Arginine | 2 | 2019 | 75 | 0.650 |
Why?
|
| Antibodies, Neutralizing | 10 | 2014 | 118 | 0.640 |
Why?
|
| Viral Proteins | 6 | 2018 | 196 | 0.640 |
Why?
|
| Binding Sites | 6 | 2020 | 670 | 0.640 |
Why?
|
| Virosomes | 1 | 2019 | 3 | 0.630 |
Why?
|
| Heparitin Sulfate | 1 | 2019 | 23 | 0.600 |
Why?
|
| Virus Replication | 1 | 2021 | 318 | 0.600 |
Why?
|
| Bacteria | 1 | 2021 | 285 | 0.590 |
Why?
|
| HIV Antibodies | 6 | 2014 | 24 | 0.530 |
Why?
|
| HIV-1 | 5 | 2013 | 747 | 0.520 |
Why?
|
| Sulfolobus | 4 | 2010 | 6 | 0.480 |
Why?
|
| Models, Molecular | 16 | 2013 | 875 | 0.440 |
Why?
|
| HIV Envelope Protein gp41 | 2 | 2013 | 7 | 0.440 |
Why?
|
| Crystallography, X-Ray | 12 | 2013 | 285 | 0.430 |
Why?
|
| Swine | 4 | 2023 | 205 | 0.420 |
Why?
|
| Virus Assembly | 5 | 2018 | 44 | 0.410 |
Why?
|
| Serine Endopeptidases | 2 | 2004 | 48 | 0.400 |
Why?
|
| Cytomegalovirus | 2 | 2004 | 49 | 0.400 |
Why?
|
| Protein Conformation | 11 | 2020 | 420 | 0.380 |
Why?
|
| DNA, Viral | 2 | 2023 | 323 | 0.350 |
Why?
|
| Rudiviridae | 1 | 2010 | 1 | 0.340 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 4 | 2014 | 17 | 0.330 |
Why?
|
| Protein Folding | 1 | 2009 | 123 | 0.300 |
Why?
|
| Molecular Sequence Data | 11 | 2016 | 1559 | 0.280 |
Why?
|
| Protein Structure, Quaternary | 6 | 2013 | 70 | 0.280 |
Why?
|
| Amino Acid Sequence | 10 | 2016 | 1188 | 0.270 |
Why?
|
| Proteins | 1 | 2009 | 383 | 0.260 |
Why?
|
| Amino Acid Substitution | 2 | 2019 | 135 | 0.250 |
Why?
|
| Antibodies, Viral | 3 | 2013 | 295 | 0.250 |
Why?
|
| Bacteriophages | 3 | 2013 | 44 | 0.240 |
Why?
|
| Archaea | 1 | 2005 | 17 | 0.240 |
Why?
|
| Bacteriophage P22 | 3 | 2010 | 6 | 0.240 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2021 | 385 | 0.240 |
Why?
|
| Animals | 10 | 2023 | 16695 | 0.230 |
Why?
|
| Amino Acid Motifs | 4 | 2019 | 94 | 0.230 |
Why?
|
| Archaeal Viruses | 3 | 2010 | 3 | 0.230 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 3 | 2012 | 15 | 0.220 |
Why?
|
| Macromolecular Substances | 3 | 2014 | 95 | 0.210 |
Why?
|
| Antibody Specificity | 3 | 2012 | 76 | 0.210 |
Why?
|
| Hydrolysis | 1 | 2023 | 98 | 0.210 |
Why?
|
| DNA Helicases | 1 | 2023 | 46 | 0.210 |
Why?
|
| Influenza Vaccines | 3 | 2012 | 55 | 0.200 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2003 | 10 | 0.200 |
Why?
|
| DNA, Circular | 1 | 2021 | 8 | 0.190 |
Why?
|
| Endonucleases | 1 | 2021 | 18 | 0.190 |
Why?
|
| Glycoproteins | 2 | 2013 | 127 | 0.180 |
Why?
|
| Adenosine Diphosphate | 1 | 2021 | 21 | 0.180 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2014 | 170 | 0.180 |
Why?
|
| Electron Microscope Tomography | 2 | 2011 | 5 | 0.180 |
Why?
|
| Genome, Viral | 1 | 2021 | 118 | 0.170 |
Why?
|
| DNA Replication | 1 | 2021 | 153 | 0.170 |
Why?
|
| Ribosome Subunits, Large | 1 | 2020 | 1 | 0.170 |
Why?
|
| Phylogeny | 2 | 2021 | 740 | 0.160 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 183 | 0.160 |
Why?
|
| Enterococcus faecalis | 1 | 2020 | 44 | 0.160 |
Why?
|
| Immunoglobulin Fab Fragments | 3 | 2014 | 13 | 0.160 |
Why?
|
| Virus Internalization | 2 | 2010 | 36 | 0.160 |
Why?
|
| Models, Theoretical | 2 | 2019 | 230 | 0.160 |
Why?
|
| Endosomes | 1 | 2019 | 34 | 0.150 |
Why?
|
| Glycosaminoglycans | 1 | 2019 | 24 | 0.150 |
Why?
|
| Heparin | 1 | 2019 | 39 | 0.150 |
Why?
|
| Molecular Structure | 1 | 2021 | 560 | 0.150 |
Why?
|
| Liposomes | 1 | 2019 | 130 | 0.140 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2018 | 84 | 0.140 |
Why?
|
| Microscopy, Electron | 4 | 2014 | 209 | 0.140 |
Why?
|
| Polysaccharides | 3 | 2013 | 70 | 0.130 |
Why?
|
| Swine Diseases | 1 | 2016 | 9 | 0.130 |
Why?
|
| Genotype | 1 | 2019 | 796 | 0.130 |
Why?
|
| Solubility | 2 | 2013 | 134 | 0.120 |
Why?
|
| AIDS Vaccines | 2 | 2013 | 25 | 0.120 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2012 | 14 | 0.120 |
Why?
|
| Cross Reactions | 2 | 2012 | 86 | 0.120 |
Why?
|
| Epitopes | 5 | 2013 | 155 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 6 | 2013 | 427 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 2 | 2013 | 301 | 0.110 |
Why?
|
| Peptide Hydrolases | 1 | 2013 | 44 | 0.100 |
Why?
|
| Molecular Mimicry | 1 | 2013 | 16 | 0.100 |
Why?
|
| Nodaviridae | 2 | 2012 | 4 | 0.100 |
Why?
|
| Escherichia coli | 3 | 2020 | 461 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2004 | 189 | 0.100 |
Why?
|
| Models, Biological | 3 | 2011 | 711 | 0.100 |
Why?
|
| Binding Sites, Antibody | 4 | 2013 | 19 | 0.100 |
Why?
|
| Influenza B virus | 1 | 2012 | 5 | 0.100 |
Why?
|
| Immunodominant Epitopes | 1 | 2012 | 28 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 89 | 0.100 |
Why?
|
| Influenza A virus | 1 | 2012 | 31 | 0.100 |
Why?
|
| Humans | 10 | 2021 | 42163 | 0.090 |
Why?
|
| Glycosylation | 4 | 2013 | 111 | 0.090 |
Why?
|
| Oligosaccharides | 1 | 2011 | 28 | 0.090 |
Why?
|
| Nucleocapsid | 1 | 2011 | 12 | 0.090 |
Why?
|
| Protein Binding | 4 | 2014 | 1076 | 0.080 |
Why?
|
| DNA | 1 | 2013 | 594 | 0.080 |
Why?
|
| RNA Viruses | 1 | 2010 | 22 | 0.080 |
Why?
|
| Conserved Sequence | 4 | 2012 | 121 | 0.080 |
Why?
|
| Bacteriophage lambda | 1 | 2009 | 11 | 0.080 |
Why?
|
| Reoviridae | 1 | 2009 | 7 | 0.080 |
Why?
|
| Algorithms | 2 | 2011 | 508 | 0.080 |
Why?
|
| Software Design | 1 | 2009 | 18 | 0.080 |
Why?
|
| Automation | 1 | 2009 | 23 | 0.080 |
Why?
|
| Chaperonin 60 | 1 | 2009 | 17 | 0.080 |
Why?
|
| Rhodopsin | 1 | 2009 | 26 | 0.080 |
Why?
|
| Databases, Protein | 1 | 2009 | 54 | 0.080 |
Why?
|
| Static Electricity | 1 | 2009 | 85 | 0.080 |
Why?
|
| Kinetics | 3 | 2010 | 698 | 0.080 |
Why?
|
| Viral Tail Proteins | 1 | 2009 | 2 | 0.080 |
Why?
|
| Cattle | 1 | 2009 | 505 | 0.070 |
Why?
|
| Mutation | 4 | 2016 | 1169 | 0.070 |
Why?
|
| Thermodynamics | 2 | 2021 | 226 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 491 | 0.070 |
Why?
|
| Sulfates | 2 | 2004 | 26 | 0.070 |
Why?
|
| Dimerization | 2 | 2004 | 115 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2009 | 400 | 0.060 |
Why?
|
| Evolution, Molecular | 2 | 2005 | 299 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2005 | 53 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2009 | 580 | 0.060 |
Why?
|
| Amino Acids | 1 | 2005 | 150 | 0.060 |
Why?
|
| Temperature | 1 | 2005 | 314 | 0.050 |
Why?
|
| Titrimetry | 1 | 2004 | 8 | 0.050 |
Why?
|
| Buffers | 1 | 2004 | 17 | 0.050 |
Why?
|
| Edetic Acid | 1 | 2004 | 23 | 0.050 |
Why?
|
| Dithiothreitol | 1 | 2004 | 18 | 0.050 |
Why?
|
| Enzyme Stability | 1 | 2004 | 35 | 0.050 |
Why?
|
| Sodium Chloride | 1 | 2004 | 54 | 0.050 |
Why?
|
| Methanobacterium | 1 | 2003 | 1 | 0.050 |
Why?
|
| Archaeal Proteins | 1 | 2003 | 9 | 0.050 |
Why?
|
| Morpholines | 1 | 2004 | 73 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2004 | 217 | 0.050 |
Why?
|
| Surface Properties | 1 | 2004 | 157 | 0.050 |
Why?
|
| Catalysis | 1 | 2004 | 191 | 0.050 |
Why?
|
| Alanine | 1 | 2003 | 33 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2003 | 107 | 0.050 |
Why?
|
| Glutamine | 1 | 2003 | 36 | 0.050 |
Why?
|
| Protein Multimerization | 2 | 2014 | 114 | 0.050 |
Why?
|
| Crystallization | 1 | 2003 | 88 | 0.050 |
Why?
|
| Fungal Proteins | 1 | 2003 | 143 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2004 | 462 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2003 | 199 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2003 | 131 | 0.050 |
Why?
|
| Hydrogen Bonding | 2 | 2011 | 143 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2016 | 273 | 0.040 |
Why?
|
| Water | 1 | 2003 | 314 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2012 | 102 | 0.040 |
Why?
|
| Bacteriophage phi 6 | 1 | 2018 | 9 | 0.040 |
Why?
|
| Proteomics | 2 | 2013 | 363 | 0.040 |
Why?
|
| Cell Line | 2 | 2012 | 1416 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2018 | 160 | 0.030 |
Why?
|
| Mice | 3 | 2012 | 6490 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 415 | 0.030 |
Why?
|
| Protein Structure, Secondary | 2 | 2009 | 185 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2006 | 140 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2006 | 271 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2014 | 41 | 0.030 |
Why?
|
| Caudovirales | 1 | 2013 | 1 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2014 | 106 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 973 | 0.030 |
Why?
|
| 1-Deoxynojirimycin | 1 | 2013 | 3 | 0.030 |
Why?
|
| Detergents | 1 | 2013 | 25 | 0.030 |
Why?
|
| Carbohydrate Sequence | 1 | 2013 | 20 | 0.030 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2013 | 20 | 0.030 |
Why?
|
| Biopolymers | 1 | 2013 | 17 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2013 | 27 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2013 | 92 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2013 | 57 | 0.020 |
Why?
|
| Alkaloids | 1 | 2013 | 46 | 0.020 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2012 | 5 | 0.020 |
Why?
|
| Complementarity Determining Regions | 1 | 2012 | 8 | 0.020 |
Why?
|
| Vaccines, Virosome | 1 | 2012 | 1 | 0.020 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 22 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2012 | 50 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2012 | 55 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 279 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 2012 | 78 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 198 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2012 | 165 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 184 | 0.020 |
Why?
|
| Mannosides | 1 | 2011 | 3 | 0.020 |
Why?
|
| Carbohydrate Conformation | 1 | 2011 | 15 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2011 | 21 | 0.020 |
Why?
|
| Immune Evasion | 1 | 2011 | 17 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 2011 | 20 | 0.020 |
Why?
|
| Glycopeptides | 1 | 2011 | 14 | 0.020 |
Why?
|
| Disaccharides | 1 | 2011 | 12 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 522 | 0.020 |
Why?
|
| Mannose | 1 | 2011 | 30 | 0.020 |
Why?
|
| Sulfolobus solfataricus | 1 | 2011 | 3 | 0.020 |
Why?
|
| Scattering, Small Angle | 1 | 2011 | 18 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 456 | 0.020 |
Why?
|
| Drug Carriers | 1 | 2012 | 169 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2010 | 62 | 0.020 |
Why?
|
| Peptides | 1 | 2013 | 357 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 686 | 0.020 |
Why?
|
| Eukaryota | 1 | 2010 | 20 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2010 | 230 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 884 | 0.020 |
Why?
|
| Particle Size | 1 | 2010 | 267 | 0.020 |
Why?
|
| Software | 1 | 2011 | 234 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2009 | 93 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2010 | 404 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2005 | 118 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2005 | 300 | 0.010 |
Why?
|
| Male | 1 | 2012 | 22779 | 0.010 |
Why?
|
| Female | 1 | 2012 | 24018 | 0.010 |
Why?
|